-
Covid-19 Volunteer Testing Network scaling up - delivering tests for GPs and care home workers
May 7, 2020, 06:12 AM by Michael CroftOXFORD, UK - May 7, 2020 -Full story- The Covid-19 Volunteer Testing Network is scaling up towards thousands of tests per day
- 6 labs around the country are now live with 20 more in the pipeline
- Local labs can deliver a fast-turnaround for their nearby GPs and care home workers
- One lab in the network identified an outbreak in a community care provider with asymptomatic staff testing positive
- Underscores the vital importance of regular screening of healthcare workers who might otherwise unknowingly be spreading the virus
-
Halfpenny Technologies, an Accumen Company, Launches COVID-19 Test Capacity and Routing Network Across 870 U.S. Hospitals to Accelerate Diagnostic Testing
May 6, 2020, 20:05 PM by Michael CroftPHOENIX, AZ - May 6, 2020 - Halfpenny Technologies, Inc., a wholly owned subsidiary of Accumen, Inc., today announced the launch of its COVID-19 Test Capacity and Routing Network (The Network)Full story -
Widening Application Scope and COVID-19 Crisis, Set to Boost Market Growth of Immunoassays, Concludes Fact.MR
May 6, 2020, 10:00 AM by Michael CroftDUBLIN 2, IRELAND - May 6, 2020 - As the number of chronic and infectious diseases compound, medical advancements have grown in equal proportionFull story -
Lessons From Personalized Medicine Can Supercharge Coronavirus Testing
May 6, 2020, 08:15 AM by Michael CroftFull storyBio-IT World Contributed Commentary | Months into the Covid-19 pandemic, the United States remains dangerously behind on testing—and we know that technology from personalized medicine can help correct the chaos.
-
Rho Experts Share Regulatory Best Practices on Product Development for the New Coronavirus
May 5, 2020, 10:50 AM by Michael CroftRESEARCH TRIANGLE PARK, NC, UNITED STATES - May 5, 2020 - WHAT: Rho, a full-service contract research organization (CRO) with a proven track record of drug development success, will outline new information from the Food and Drug Administration (FDA) on the new coronavirus (COVID-19) pandemic as it relates to ongoing and planned clinical research in an upcoming webinar, "Potential COVID-19 Products: Choosing the Right Path with FDAFull story -
GRAIL Founder Returns To Illumina As CTO
May 4, 2020, 16:45 PM by Michael CroftBio-IT World | Illumina today announced the appointment of Alex Aravanis as Chief Technology Officer. Dr. Aravanis will be responsible for leading Illumina’s research and technology development functions and the innovation engine for next-generation sequencing platforms and applications, accelerating technology breakthroughs and translation to the clinic.Full story -
SEKISUI XenoTech Expands Access to Top-Tier DDI Expertise & Consultancy
May 4, 2020, 09:27 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - May 4, 2020 - SEKISUI XenoTech is expanding opportunities for clients to work with top-tier consultants to evaluate drug-drug interaction potential of their drug candidate and bolster their preclinical data package for regulatory submissionFull story -
Follow the Money: New European Fund, All-Flash Storage, More
May 4, 2020, 08:55 AM by Michael CroftBio-IT World | New life sciences fund closes in Europe, big investments in VAST Data’s all flash storage, AI-written code, Lifebit’s CloudOS, Scopio Labs’s digital microscopy, microbiome tests and much more.Full story -
Blockchain and its Impact on Epidemiology for COVID-19
May 4, 2020, 08:15 AM by Michael CroftFull storyBio-IT World Contributed Commentary | With the recent outbreak of COVID-19, epidemiologists around the world are researching and creating models on how to contain the disease. Blockchain technology exemplifies its use case within epidemiology by streamlining the process of distribution and providing trustworthy data.
-
CHELSIO AND RYUSSI DEMONSTRATE END-TO-END iWARP RDMA BETWEEN WINDOWS 10 ENTERPRISE AND MoSMB SMB3 SERVER
May 3, 2020, 05:33 AM by Michael CroftSUNNYVALE, CALIFORNIA - Feb 12, 2020 - Chelsio Communications, Inc., a leading provider of high performance (1Gb/10Gb/25Gb/40Gb/50Gb/100Gb) Ethernet Unified Wire adapters and ASICs for storage networking, virtualized enterprise datacenters, cloud service installations, and cluster computing environments, and Ryussi America, Inc, a Storage & Systems Product Development and Consulting company, today announced the results of the performance of Chelsio Terminator 6 (T6) iWARP RDMA adapters with Windows 10 Enterprise Client RDMA feature enabling high-speed access to the Ryussi MoSMB SMB3 server using SMB DirectFull story -
Data Kits, Supercomputers, And Llamas: Bio-IT Community Leaves No Stone Unturned In COVID-19 Research
May 1, 2020, 09:00 AM by Michael CroftBio-IT World | New insights from the global bio-IT community show progress in fight against COVID-19.Full story -
The New Technology CAR-T Is Expected to Overcome AIDS After Being Transformed
May 1, 2020, 08:01 AM by Michael CroftSHIRLEY, NY, UNITED STATES - May 1, 2020 - CAR-T is the short name for Chimeric Antigen Receptor T-Cell Immunotherapy. To put it simply, CAR-T is to transform the patient's immune T cells in vitro to make them recognize the antigens on the surface of tumor cells, and then transfer these cells back to the patient to achieve the therapeutic effect of identifying and killing cancer cellsFull story -
Igneous Launches Data Discovery Product
Apr 30, 2020, 11:00 AM by Michael CroftFull storyBio-IT World Earlier this week, Igneous, the SaaS data management company for file-intensive environments announced enhancements to DataDiscover and DataFlow. Igneous DataFlow now enables data-heavy organizations to move data in native format from where it lives to where it needs to be, on-premises or cloud. Igneous DataDiscover catalogs all data where it lives. Now organizations can enable end users to see their data their way and find what’s important to them.
-
PHARMASEAL expands Engility® Trial Management Platform with the addition of eTMF Document Storage
Apr 30, 2020, 06:32 AM by Michael CroftNOTTINGHAN, UK - Apr 29, 2020 - PHARMASEAL, an innovative provider of enterprise trial management solutions expands the capability of the Engility® clinical trial management platformFull story -
Creative Diagnostics Launches SARS-CoV-2 Antigens and Antibodies for Research Use
Apr 30, 2020, 04:35 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Apr 1, 2020 - As a global leading supplier of of raw materials, antibodies, and reagents for bio-technology industry, Creative Diagnostics now launches SARS-CoV-2 antigens and antibodies for global researchers working on the novel coronavirusFull story -
COVID-19, Insilico Medicine, Discngine, And More: News From April 2020
Apr 29, 2020, 09:40 AM by Michael CroftFull storyBio-IT World April featured exciting new, products, and partnerships from around the bio-IT community from innovating companies, organizations, and universities, including Discngine and Insilico Medicine, as well as recent attempts to combat COVID-19.
-
Independent site management organisation Panthera expands vaccine trial capacity
Apr 29, 2020, 09:21 AM by Michael CroftPRESTON, UNITED KINGDOM - Apr 29, 2020 - Panthera is now undertaking Phase II, III and IV vaccine trials on behalf of its pharma and CRO clients across its growing network of sites in the UKFull story -
Accurics Launches with a Vision of Making Cloud Infrastructure Security Ubiquitous
Apr 28, 2020, 19:03 PM by Michael CroftPLEASANTON, CA, UNITED STATES - Apr 28, 2020 - Pleasanton, CA - April 28, 2020 - Accurics, the 'code-to-cloud' security specialist, came out of stealth mode today to announce the formal launch of the companyFull story -
St. Jude Cloud Announces New App-Driven User Interface, Functionality
Apr 28, 2020, 12:05 PM by Michael CroftFull storyBio-IT World | St. Jude has released a new brand and user interface for the St. Jude Cloud, an initiative the research hospital launched two years ago in collaboration with Microsoft and DNAnexus. The vision of St. Jude Cloud has significantly expanded to include a much more scalable framework for sharing for all of St. Jude data, not just the genomics data.
-
Heart Valve Devices Market to Witness Astounding Growth, Invigorated by Adoption of Transcatheter Aortic Valve Replacement (TAVI) Procedures, Concludes Fact.MR
Apr 28, 2020, 11:35 AM by Michael CroftDUBLIN 2, IRELAND - Apr 28, 2020 - The incidences of heart diseases have registered an uptick in the recent past. Moreover, increased life expectancy has burgeoned the geriatric population pool, thus augmenting demand for heart valve devicesFull story